Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor …
N Semesiuk, A Zhylchuk, N Bezdenezhnykh… - Experimental …, 2013 - irbis-nbuv.gov.ua
Background: in recent years, the presence of disseminated tumor cells (DTC) in bone
marrow (BM) of patients with breast cancer (BC) is considered as an important clinical …
marrow (BM) of patients with breast cancer (BC) is considered as an important clinical …
[HTML][HTML] Many roles of CCL20: emphasis on breast cancer
CCL20 or MIP3α is a small~ 8 kDa protein primarily expressed in the liver, colon, prostate,
cervix, and skin. The cellular receptor for CCL20 is CCR6. CCl20 unlike many other …
cervix, and skin. The cellular receptor for CCL20 is CCR6. CCl20 unlike many other …
[PDF][PDF] Current Progress and Future Prospects of aptamer-based cancer therapy
S Catuogno, CL Esposito - Journal of Postdoctoral Research …, 2013 - postdocjournal.com
Aptamers are short, structured, single-stranded RNA or DNA ligands that bind with high
affinity to target molecules. They have a number of important advantages over proteins as …
affinity to target molecules. They have a number of important advantages over proteins as …
[PDF][PDF] DISSEMINATED) TUMOR CELLS AND EN HANCED) LEVEL OF SOMIE GGGGGGGL GGG GGGG GGGLGLG GGGL GGLGGGLGL LSLLLLS LL LL GLL …
N Semesiuk, A Zhylchuk, N Bezdenezhnykh… - Experimental …, 2013 - jnas.nbuv.gov.ua
Background: In recent years, the presence of disseminated tumor cells (DTC) in bone
marrow (BM) of patients with breast cancer (BC) is considered as an important clinical …
marrow (BM) of patients with breast cancer (BC) is considered as an important clinical …